- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Immune cells in cancer
- Nanoplatforms for cancer theranostics
- Phagocytosis and Immune Regulation
- Epigenetics and DNA Methylation
- Ferroptosis and cancer prognosis
- Cancer, Lipids, and Metabolism
- Immune Cell Function and Interaction
Sun Yat-sen Memorial Hospital
2023-2024
Sun Yat-sen University
2023-2024
Guangzhou Regenerative Medicine and Health Guangdong Laboratory
2023
Abstract The therapeutic efficacy of chemotherapy is in part a result its ability to enhance adaptive antitumor immune responses. However, tumor cells exploit various evasion mechanisms escape the attack and blunt chemosensitivity. Herein, we report that through single-cell profiling microenvironment, identified subset CD161-overexpressing CD8+ T enriched chemoresistant tumors. CD161 engagement repressed calcium influx cytolytic capacity acid sphingomyelinase activation ceramide generation....
<div>Abstract<p>The therapeutic efficacy of chemotherapy is in part a result its ability to enhance adaptive antitumor immune responses. However, tumor cells exploit various evasion mechanisms escape the attack and blunt chemosensitivity. Herein, we report that through single-cell profiling microenvironment, identified subset CD161-overexpressing CD8<sup>+</sup> T enriched chemoresistant tumors. CD161 engagement repressed calcium influx cytolytic capacity acid...
<p>Supplementary figures S1-S8 and tables S1-S6</p>
<div>Abstract<p>The therapeutic efficacy of chemotherapy is in part a result its ability to enhance adaptive antitumor immune responses. However, tumor cells exploit various evasion mechanisms escape the attack and blunt chemosensitivity. Herein, we report that through single-cell profiling microenvironment, identified subset CD161-overexpressing CD8<sup>+</sup> T enriched chemoresistant tumors. CD161 engagement repressed calcium influx cytolytic capacity acid...
<p>Supplementary figures S1-S8 and tables S1-S6</p>